title: Osteomyelitis of the ribs in the antibiotic era.
abstract: A total of 106 cases of rib osteomyelitis were reviewed, including 2 cases described in detail. Mycobacterial and bacterial infections accounted for 47 cases each. Fungal rib osteomyelitis occurred in 11 cases and 1 case was caused by Entamoeba histolytica. Most cases occurred in children and young adults. The mean duration of symptoms before diagnosis was 16, 26 and 32 weeks for bacterial, mycobacterial and fungal rib osteomyelitis, respectively. Common clinical signs were fever (73%), soft tissue mass (64%) and chest pain (60%). Route of infection was defined in 85 cases: 62% from contiguous spread and 38% via haematogenous route of infection. Eighty-nine percent had a favourable outcome after antimicrobial therapy with or without surgery. In conclusion, rib osteomyelitis is a rare infection of various aetiologies. The majority of cases occur in children and young adults and its diagnosis is usually delayed for several weeks.
authors.affiliation: Department of Internal Medicine C, Rabin Medical Center, Sackler School of Medicine, Tel Aviv University, Petach Tikvah, Israel.
authors.forename: J
authors.initials: J
authors.lastname: Bishara
authors.forename: D
authors.initials: D
authors.lastname: Gartman-Israel
authors.forename: M
authors.initials: M
authors.lastname: Weinberger
authors.forename: S
authors.initials: S
authors.lastname: Maimon
authors.forename: G
authors.initials: G
authors.lastname: Tamir
authors.forename: S
authors.initials: S
authors.lastname: Pitlik
mesh_terms: D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002648:Child; D005260:Female; D006801:Humans; D009169:Mycobacterium tuberculosis; D010019:Osteomyelitis / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology; D012272:Ribs; D016868:Serratia Infections / Q000175:diagnosis / Q000188:drug therapy; D012706:Serratia marcescens; D014394:Tuberculosis, Osteoarticular / Q000175:diagnosis / Q000188:drug therapy
chemical_list: D000900:Anti-Bacterial Agents